Ecolab 10-Qquarter ended 2026-06-30
Restructuring
CoolIT acquisition adds data-center liquid cooling, while higher capex and acquisition financing increase cash demands.
Filed 2026-08-06 08:05 ET
Key figures · Q2 FY2026 · period ended 2026-06-30
- Revenue$4.4BYoY +9.7%QoQ +8.6%
- Operating income$757.9MYoY +6.7%QoQ +21.8%
- Net income$534.9MYoY +2.0%QoQ +23.6%
- Total assets$29.9BQoQ +19.5%
- Total debt$13.2BQoQ +55.1%
How total debt adds up Long-term debt $11,905M + Short-term debt $1,271M Total debt $13,176M Lines as the filer presents them on its balance sheet.
- Shareholders' equity$10.1BQoQ +0.5%
- Tangible book value−$2.8BQoQ +4.9%
How this filing reads
- Health−0.2H1 free cash flow was $587M against $13.2B debt, with $5.14B cash before CoolIT payment.
- Momentum+0.2Q2 revenue grew 9.7%, while net income rose 2.0% and margin fell 70bp.
- Outlook0.0Management targets $325M annualized savings by end-2027 as CoolIT adds $4.75B of acquisition exposure.
Executive Summary
Ecolab is expanding beyond its traditional water, hygiene and infection-prevention businesses into semiconductor water systems and data-center cooling, culminating in the $4.75B CoolIT acquisition after quarter-end. Q2 revenue grew 9.7%, but organic growth was 5% and net income rose only 2.0%, as higher costs, special charges, interest and taxes diluted operating gains. High-Tech water and Life Sciences offer compelling growth opportunities, while higher capital spending reduced free cash flow despite increased operating cash flow. The investment thesis increasingly depends on converting technology-market growth and restructuring savings into cash sufficient to support acquisition financing.
Key Financial Highlights
| Metric | Q2 2026 | H1 2026 / quarter-end | Investor interpretation |
|---|---|---|---|
| Revenue | $4.42B; +9.7% Y/Y | $8.48B; +9.9% Y/Y | Acquisitions and currency supplemented organic growth. |
| Gross profit | $1.95B | $3.72B | Gross margins declined 70bp in both periods. |
| GAAP operating income | $758M; +6.7% Y/Y | $1.38B; +9.0% Y/Y | Earnings growth lagged sales growth. |
| Net income | $535M; +2.0% Y/Y | $968M; +4.4% Y/Y | Financing costs and higher taxes restrained earnings. |
| GAAP diluted EPS | $1.90; +3.3% Y/Y | $3.42; +5.2% Y/Y | Lower share counts supported per-share growth. |
| Operating cash flow / free cash flow | — | $1.18B / $587M | Operating cash flow increased; free cash flow fell 4.8%. |
| Total assets / total equity | — | $29.9B / $10.1B | Assets include acquisition funding awaiting deployment. |
| Tangible common equity attributable to Ecolab | — | ≈$(2.81)B | Goodwill and intangible assets exceed book equity. |
- Growth quality: Q2 organic growth comprised 4 percentage points of pricing and 1 point of volume; acquisitions and favorable currency added 3 and 2 points, respectively. Organic gross margin was broadly flat, while lower selling, general and administrative expense relative to sales supported profitability.
- Cash conversion: H1 capital expenditures increased to $589M from $455M; receivables and inventories absorbed $328M, and operating cash flow included $60M of one-time Ovivo employee equity-incentive payments.
- Financing: Total debt carrying amount reached $13.2B from $8.13B at year-end following $5.0B principal of senior-note issuance. Cash reached $5.14B before CoolIT closed; H1 net interest expense increased 20% to $146M.
- Capital returns: H1 repurchases of $669M accompanied a net share-count decline of 1.70M, or 0.6%, to 280M; issuance offset part of the 2.54M shares repurchased. Dividends paid were $424M, taking combined returns above free cash flow.
- Earnings adjustments: Special charges totaled $57.7M in Q2 and $115M in H1, principally restructuring and integration costs. GAAP EPS of $1.90 and $3.42 compares with adjusted EPS of $2.09 and $3.79, respectively.
Business Developments
- Technology expansion: Ovivo Electronics, acquired for $1.60B net of cash in 12/2025, adds semiconductor ultrapure-water capabilities. CoolIT, acquired on 7/2/2026 for $4.75B subject to adjustments, adds data-center liquid cooling; its purchase price is outside the quarter-end balance sheet.
- Growth mix: Q2 High-Tech organic sales grew 29% on microelectronics and data-center wins, while Life Sciences grew 15% and Pest Elimination 7%. Heavy Water declined 1%, showing that stronger technology and specialized-service demand is offsetting weaker industrial markets.
- Productivity investment: One Ecolab has delivered $180M in cumulative savings; management targets $325M in annualized savings by end-2027. Phased enterprise resource planning upgrades seek transaction-processing efficiency but require testing of affected financial controls.
Risk Assessment
- Acquisition execution and valuation: CoolIT materially increases integration exposure, while existing goodwill and net intangibles total $12.9B; weaker acquired-business performance could impair returns and asset values.
- Financing and cash demands: Acquisition financing, elevated capital spending and shareholder distributions compete for cash, while quarter-end liquidity precedes payment for CoolIT.
- Cost and pricing pressure: Energy, commodity and logistics inflation pressured Global Water’s Q2 fixed-currency operating margin to 15.7% from 16.4%; surcharge recovery depends on customer acceptance.
- International exposure: 47% of H1 sales came from outside the United States, exposing growth and earnings to currency, geopolitical and trade-policy changes.
- Customer credit: Expected-credit-loss allowances increased to $101M from $74.1M, alongside higher bad-debt expense, creating additional collection and cash-conversion risk.
This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: the company's 10-Ks on SEC.
Strategic Outlook and Investor Actionables
Management is betting that technology-market expansion and productivity savings can overcome cost inflation and acquisition financing burdens. The opportunity is faster growth in water-intensive and cooling-intensive markets; the threat is growth that requires more capital without delivering proportional cash returns.
- CoolIT integration: The $4.75B acquisition works if subsequent filings show sustained acquired-business growth and earnings contributions; shrinking operations or impairments would undermine the bet.
- Specialized-market demand: High-Tech’s 29% and Life Sciences’ 15% Q2 organic growth provide the baseline; sustained growth supports diversification, while sharp deceleration challenges the demand thesis.
- Restructuring economics: Against $180M of cumulative savings and management’s end-2027 target, success means expanding margins while sales hold; persistent charges without improvement indicate poor execution.
- Financing and cash conversion: H1 free cash flow of $587M and net interest expense of $146M establish the baseline; improving cash generation and debt reduction would validate funding capacity, while rising borrowing and interest would weaken it.
Figures are computed from the filing's XBRL data; the summary and scores are written by an AI model reading the filing.
Model 006 · prompt bdad6d7239